Compared with healthy peripheral blood, a marked reduced population of circulating CD8+ T cells is observed in blood from patients with multiple malignancies, including colorectal cancer, Hodgkin lymphoma, breast cancer, and NSCLC [237, 238, 239, 240]. This evidence concerns the gene CD8A and non-small cell lung carcinoma.